Transient receptor potential channel C5 in cancer chemoresistance

Dong-xu He1, Xin Ma2

  • 1National Engineering Laboratory for Cereal Fermentation Technology, Jiangnan University, Wuxi 214122, China.

Acta Pharmacologica Sinica
|December 15, 2015
PubMed

Insights

Transient Receptor Potential (TRP) channels, particularly TRPC5, are implicated in cancer progression and chemoresistance by disrupting calcium homeostasis. Targeting TRPC5 offers a potential therapeutic strategy to overcome cancer drug resistance.

Area of Science:

  • Molecular Biology
  • Oncology
  • Physiology

Background:

  • The Transient Receptor Potential (TRP) superfamily comprises at least 28 mammalian homologs.
  • TRP channels are crucial for physiological functions, regulating cation permeability.
  • Dysregulation of TRP channels is linked to various diseases.

Purpose of the Study:

  • To provide an overview of mammalian TRP channels.
  • To focus on the role of TRPC5 in cancer.
  • To explore TRPC5 as a therapeutic target for cancer chemoresistance.

Main Methods:

  • Literature review of mammalian TRP channels.
  • Analysis of TRPC5's role in cancer cell calcium homeostasis.
  • Discussion of therapeutic strategies targeting TRPC5.

Main Results:

  • TRPC5 dysregulation disrupts calcium homeostasis in cancer cells.
  • This disruption activates pathways promoting cancer progression and chemoresistance.
  • TRPC5 plays a significant role in cancer chemoresistance.

Conclusions:

  • TRPC5 is a key player in cancer progression and chemoresistance.
  • Targeting TRPC5 directly or its related pathways could overcome chemoresistance.
  • TRPC5 presents a promising target for novel cancer therapies.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.5K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.3K
Thermosensation01:43

Thermosensation

Peripheral thermosensation is the perception of external temperature. A change in temperature (on the surface of the skin and other tissues) is detected by a family of temperature-sensitive ion channels called Transient Receptor Potential, or TRP, receptors. These receptors are located on free nerve endings. Those detecting cold temperatures are closer to the surface of the skin than the nerve endings detecting warmth. These thermoTRP channels, while temperature selective, have relatively...
35.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K